Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Jennifer R. Eads, MD

Jennifer R. Eads, MD Physician

Physician Lead GI Clinical Research Associate Professor of Clinical Medicine

Dr. Eads is employed by Penn Medicine.

Call 800-789-7366 Request a Callback
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 2009
  • Medical Oncology, 2012

Clinical Expertise:

  • Anal Cancer
  • Anorectal Cancer
  • Appendix Cancer
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Carcinoid of the Stomach
  • Carcinoid Tumor of Pancreas
  • Carcinoid Tumors
  • Colon Cancer Chemotherapy
  • Colon Tumors
  • Gallbladder Mass
  • Gastrin Secreting Tumor of Pancreas
  • Hepatobiliary Malignancies
  • Hereditary Colon Cancer
  • Hereditary Nonpolyposis Colorectal Cancer
  • Immunotherapy
  • Insulinoma
  • Liver Cancer
  • Malignant Carcinoid Tumor of the Esophagus
  • Malignant Carcinoid Tumor of the Rectum
  • Malignant Carcinoid Tumor of the Stomach
  • Malignant Neoplasm of Pancreatic Duct
  • Malignant Rectal Neoplasm
  • Malignant Tumor of Extrahepatic Bile Duct
  • Metastatic Colon Cancer
  • Metastatic Pancreatic Cancer
  • Neuroendocrine Tumor of the Extrahepatic Bile Ducts
  • Neuroendocrine Tumor of the Gallbladder
  • Pancreas Head Cancer
  • Pancreas Tail Cancer
  • Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
  • Recurrent Colorectal Cancer
  • Small Bowel Cancer
  • Small Intestine Cancer
  • Squamous Cell Carcinoma of the Esophagus
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Tufts University School of Medicine
Residency: University Hospitals Case Medical Center
Fellowship: University Hospitals Case Medical Center

Memberships

American Society of Clinical Oncology, National Cal Aggie Alumni Association, Local Cancer Therapeutics Evaluation Program, National Eastern Cooperative Oncology Group, National North American Neuroendocrine Tumor Society, National

Hospital Affiliation

Dr. Eads is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

neuroendocrine tumors and esophagogastric cancer

Selected Publications:

Dreyfuss AD, Barsky AR, Plastaras JP, Ben-Josef, Eads JR, Metz JM, Wojcieszynski AP: The efficacy of definitive concurrent proton chemoradiotherapy for esophageal cancer PTCOG-NA abstract book : 2019.

Heckert J, Botterbusch S, Kipnis S, Bennet B, Creamer C, Alderson A, Eads J, Soulen M, Pryma D, Mankoff D, Metz D, Katona B: Initial experience with peptide receptor radionuclide therapy (PRRT) for the treatment of neuroendocrine tumors (NETs) at a tertiary care United States center North American Neuroendocrine Tumor Society Abstract book : 2019.

Barsky AR, Dreyfuss AD, Plastaras JP, Ben-Josef E, Eads JR, Metz JM, Wojcieszynski AP: The toxicity profile of definitive concurrent proton chemoradiothearpy for esophageal cancer PTCOG-NA abstract book : 2019.

Heckert JM, Eads JR, Soulen MC, Pryma DA, Mankoff DA, Metz DC, Katona BW: Initial experience with peptide receptor radionuclide therapy (PRRT) for the treatment of neuroendocrine tumor (NET) at a tertiary care United States center Digestive Disease Week abstract book : 2019.

Lee H, Eads JE, Pryma DA: Standardized uptake values on 68Ga-DOTATATE PET/CT predict response to somatostatin analog therapy in gastroenteropancreatic neuroendocrine tumors Radiological Society of North America (RSNA) 2019 Annual Meeting : 2019.

Eads JR, Krishnamurthi SK, Saltzman JN, Bajor DL, Vinayak S, Barnholtz-Sloan J, Meropol NJ, Markowitz SD, Wang Z: Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors J Clin Oncol 36 : 2018.

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB 3rd, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano, T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW 2nd, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha, NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G.: NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 J Natl Compr Canc Netw 16 : 693-702,2018.

Zhao Y, Eads JR, Bajor D, Wang Z: Targeting glutamine addiction of PIK3CA mutant colorectal cancers: From preclinical models to clinical trials AACR annual meeting abstract book : 2018.

Kim SM, Eads JR: Systemic therapy for the management of neuroendocrine tumor liver metastases Primary and Metastatic Liver Tumors: Treatment Strategy and Evolving Therapies : 2017.

Wu H, Opneja A, Sutter C, Eads JR, Tavri S.: Evidence based review of non-surgical management of colorectal cancer liver metastasis and the evolving role of interventional radiology Digestive Disease Interventions : 2017.

Academic Contact Info

Perelman Center for Advanced Medicine
10th Floor South Pavilion

Philadelphia, PA 19104
Patient appointments: 800-789-7366 (PENN)